Nebula Study - Screener Apps and HSAT vs. PSG Comparison
Completed · Not applicable
Conditions studied: Sleep Apnea, Obstructive
In brief
This is a prospective, unblinded, open-label, single group study. All subjects will undergo concurrent screener app, HSAT testing, and in-lab polysomnography.
Key facts
- Study ID
- NCT04597749
- Run by
- ResMed
- People needed
- 50
- Starts
- 2020-10-27
- Expected to finish
- 2021-01-20
- Last updated by the study team
- 2021-02-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Participant is 18 years of age or older
- Participant is willing to provide informed consent
- Participant is willing to participate in all study related procedures
You may not qualify if…
- Unable to cease PAP therapy during PSG (if currently using)
- Requires use of oxygen therapy during sleep
- Diagnosis of untreated clinically relevant sleep disorder (other than SDB)
- Pregnant
- Participant is unsuitable to participate in the study in the opinion of the investigator
- Participant has a permanent pacemaker, sustained non-sinus cardiac arrhythmias, and/or takes alpha blocker or short acting nitrate medication.
Where it is running
- Clayton Sleep Institute — Maplewood, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.